Yes to the higher price from my perspective. IF approved.
Price by share market will also depend on the NEU strategy in how they will proceed from a successful FDA decision.
Eg.
Will they be an R&D company monetising assests by upfronts+milestones+royalties and distributing the bulk of profits for shareholders. My desired option.
Go it alone with future developments.
A bit of both.
.
.
.
Yes to the higher price from my perspective. IF approved.Price...
-
- There are more pages in this discussion • 9,039 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.40 |
Change
1.130(8.52%) |
Mkt cap ! $1.840B | |||
| Open | High | Low | Value | Volume |
| $13.80 | $14.45 | $13.53 | $15.04M | 1.062M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 871 | $14.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.42 | 3650 | 3 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |